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Abstract
Background: Gaps between research knowledge and practice have been consistently reported.
Traditional ways of communicating information have limited impact on practice changes. Strategies
to disseminate information need to be more interactive and based on techniques reported in
systematic reviews of implementation of changes. There is a need for clarification as to which
dissemination strategies work best to translate evidence into practice in neonatal units across
England. The objective of this trial is to assess whether an innovative active strategy for the
dissemination of neonatal research findings, recommendations, and national neonatal guidelines is
more likely to lead to changes in policy and practice than the traditional (more passive) forms of
dissemination in England.
Methods/design: Cluster randomised controlled trial of all neonatal units in England (randomised
by hospital, n = 182 and stratified by neonatal regional networks and neonatal units level of care)
to assess the relative effectiveness of active dissemination strategies on changes in local policies and
practices. Participants will be mainly consultant lead clinicians in each unit. The intervention will be
multifaceted using: audit and feedback; educational meetings for local staff (evidence-based lectures
on selected topics, interactive workshop to examine current practice and draw up plans for
change); and quality improvement and organisational changes methods. Policies and practice
outcomes for the babies involved will be collected before and after the intervention. Outcomes will
assess all premature babies born in England during a three month period for timing of surfactant
administration at birth, temperature control at birth, and resuscitation team (qualification and
numbers) present at birth.
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Background
Patient care often does not take into account new research
findings. Studies in the United States suggest that the care
of 30 to 40% of patients is not based on up-to-date scien-
tific knowledge [1,2]. Health care research consistently
finds a gap between research evidence and actual practice
in the delivery of care [3]. The main conclusions from a
large systematic review on interventions to disseminate
information and change clinical practice were a limited or
mixed effect of the traditional more passive ways used by
health professionals to keep up-to-date with their practice
(educational material, conferences and courses) [3]. Even
if a practitioner is aware of new findings, barriers to
change may hamper local changes in practice [3]. There is
growing evidence of the effectiveness of different interven-
tions to bring change in clinical practice [4-6], and their
knowledge may help to design dissemination strategy [3].
Relevant literature
A systematic review [7] of the main individual interven-
tions studied showed that the most promising methods
were: continuing medical education activities based on
'interactive workshops' [8]; educational outreach by
experts or trained facilitators, referred to as academic
detailers ('face to face visit') [9,10]; use of local opinion
leaders ('champions') [11,12]; audit and feedback espe-
cially when baseline adherence to recommended practice
is low [13], and use of reminders [14,15]. The effect of any
of these interventions considered separately on policy and
practice changes are modest to moderate (10 to 15%) [3].
Combined interventions (multifaceted interventions)
aiming at acting on different levels of barriers to change
may be more effective than individual interventions [3].
There is nevertheless imperfect evidence to support deci-
sions regarding strategies that are likely to be appropriate
and effective under varying circumstances [15] and con-
siderable judgement is required in the choice of interven-
tion(s) to influence changes [15]. Which dissemination
strategies work best in a setting such as neonatal care in
England therefore need further clarification. One group
has been working previously on the effect of active dis-
semination of neonatal research in the USA (Vermont
Oxford Network) using data collected by a collaborative
network of selected neonatal units [16]. They published a
multifaceted collaborative quality improvement interven-
tion to promote evidence-based surfactant treatment for
preterm infants born at 23–29 weeks' gestation [17]. The
study design was a cluster randomised controlled trial
(CRCT). The intervention comprised audit and feedback,
lectures on reviews of the evidenced-based literature, an
interactive training workshop and ongoing faculty sup-
port via conference calls and email. This package of inter-
vention was associated with a significant improvement
(40%) in the process of care leading to earlier surfactant
administration to improve survival in preterm infants of
an order of magnitude much higher than the general 10–
15% effect described in the literature. Possible explana-
tions for this could be: a more targeted audience of clini-
cians working within a well defined subspecialty
(neonatology); the enrolment of a tight network of clini-
cians working together and receptive to quality improve-
ment and benchmarking of their performance [17]; a two-
day interactive workshop based on a collaborative
improvement initiative [17,18]; social networking during
the meeting, which has been shown to contribute to the
success of collaborative initiatives [19]; interactive net-
working with good communication between the main
centre collecting evidence and detailing it proactively to
the different hospitals in the network which has been
shown in a recent systematic review to increase the pros-
pects for research use among policy-makers [20]; and the
use of the continuous quality improvement concept
applied through the Rapid Cycle Improvement Process
(RCIP) introduced in the Vermont Oxford North Ameri-
can Neonatal Network [16] by Paul Plsek [18,21].
Parallel work from the Health Services Management Cen-
tre (HSMC) in the UK has built on the organisational
development cycle [22]. The main approaches, models
and conceptual frameworks have been applied in a
number of settings in the NHS and partner agencies [23].
The theoretical approach informs the practical process of
planned change and provides a framework to introduce
other research and theories focussed on leading and man-
aging change and transition. The approach recognises and
uses participants' experiential learning and employs met-
aphors to elicit experiences of change [24]. Other useful
models include: the importance of recognising transition
through exploring [25-27]; the emotions associated with
the human dimensions of change including loss [28]; and
an individual's personal capacity for change [29]. The the-
oretical and experiential approaches may be enhanced by
practical hints, tips, and tools for local use. The choice of
active participants in the change process may be crucial. In
addition to the role of opinion leaders (often as classified
by peers), employee participation theory suggests self-
nominees (volunteers) may enhance local communica-
tions and coordination, employee motivation, and
employee capability [30-33] in the change process.
The case study
The UK Confidential Enquiry into Maternal and Child
Health (CEMACH) has a nationwide network for data col-
lection and assesses standards of care in a wide range of
perinatal clinical areas. One CEMACH study, Project 27/
28, reported variations in standards of care that might
have contributed to the death of preterm babies born at
27 or 28 weeks' gestation [34]. Gaps found between evi-
dence and practice led to the development of recommen-Implementation Science 2007, 2:33 http://www.implementationscience.com/content/2/1/33
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dations for future practice [34]. As a consequence, a new
national position statement on the early care of premature
babies has been developed by the UK's leading national
institution for clinical governance in neonatology, the
British Association of Perinatal Medicine (BAPM) [35].
Based on the literature described above, it was felt
unlikely that a similar approach to disseminating these
new recommendations alone would have major effects on
new policies and practices at local hospital level. An
attempt to measure the impact on policy and practice of a
previous CEMACH report in 1998 concluded that front-
line staff rarely have consistent access to the written
report, and that internal dissemination was often faulty
[36]. One of the recommendations made to improve dis-
semination was the production of video/audio materials
(educational material) for professional development
meetings to be sent to a single lead disseminator [36]. As
a consequence, a "dissemination package" of the main
findings and recommendations was sent to each Trust in
England, Wales and Northern Ireland (a PowerPoint pres-
entation to inform discussion at local hospital clinical
governance meetings).
As an attempt to evaluate the impact on policy and prac-
tice of the main Project 27/28 report and the usefulness of
the slide dissemination package, CEMACH sent a ques-
tionnaire to key potential UK recipients. Responses were
received from 94 out of 262 neonatal/paediatric clinicians
(36%), and 86 out of 183 acute Trusts with maternity serv-
ices nationally (47%). Not all respondents answered all
questions. Approximately three-quarters of the sample
said they recalled receiving the dissemination package,
and most of these reported using the slide package, find-
ing it useful for raising awareness of the clinical issues and
fostering the initiation and/or consolidation of policy and
practice changes. They particularly appreciated the presen-
tations specifically tailored for different audiences.
Although these responses suggested that dissemination
initiatives might be helpful, it was difficult to draw firm
conclusions from the poor response rate. Therefore, we
felt that a more scientifically robust evaluation of innova-
tive strategies for the dissemination of information would
be needed [37] to improve knowledge transfer leading to
policy and practice changes in the care of premature
babies in England.
Objective
The main aim of this study will be to use the rigour of a
randomised controlled trial in an evaluation comparing
the effects of different approaches on policy and practice
in the care of preterm babies in England. The specific
objective will be to assess whether an innovative 'active'
strategy for the dissemination of neonatal research find-
ings, recommendations, and national neonatal position
statement is more likely to lead to changes in policy and
practice than a more passive form of dissemination
involving just circulating the 27/28 Report, sending the
dissemination slide package to hospital staff, and making
the guidelines available on the website.
Methods/design
When the intended effect is practice and policy changes at
an institutional level, cluster randomised controlled trials
(CRCTs) where randomisation is by hospitals allowing
the delivery of the intervention to be focused on the
whole staff is the most appropriate design [37]. We will
therefore conduct a CRCT (randomised by hospital) to
assess the relative effectiveness of dissemination strate-
gies. The findings of Project 27/28 and particular aspects
of the new British Association of Perinatal Medicine
(BAPM) position statement will be used as the case study.
Participants
The main participants in the BLISS cluster randomised
controlled trial of the Effect of 'Active Dissemination of
Information' on standards of care for premature babies in
England (The BEADI Study) will be clinicians from neo-
natal units, although data will also be collected about pre-
mature babies. All neonatal units in England (182
hospitals in England with neonatal intensive care facilities
for premature babies) were identified by CEMACH at the
beginning of 2006 (Fig 1). Neonatal units have been ran-
domised to the active arm or control (Fig 1) and the ran-
domisation process stratified by neonatal networks (n =
25) based in different health regions and by units' level of
care delivered (level one to three). Some hospitals desig-
nated as level two to three or 2.5 were classified as level
two. To allow randomisation to be reproduced within
each strata, data were ordered by network and level of care
in ascending order and then by name of hospital by alpha-
betic order. Data from Excel dataset was imported into sta-
tistical computer software Stata 9. Stata 9 does not directly
allocate a treatment (active arm or passive) within each
stratum, but generates a list of block stratified randomisa-
tion code, and within each block it allocates a treatment
at random. The programme generates a series of blocks of
varying size (two, four, or six) for each stratum and then
allocates treatment randomly within each block. Because
the number of hospitals within each block is variable,
some of the treatment codes (allocation to active or pas-
sive treatment) were not used. The unused allocations
within each stratum were discarded. This process was
likely to generate some allocation imbalance. Among the
182 hospitals enrolled in the Epicure2 study that were
randomised, 86 were allocated to the active arm and 96 to
the control group (Fig 1).Implementation Science 2007, 2:33 http://www.implementationscience.com/content/2/1/33
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Clinicians from the neonatal units randomised to the
active arm will be approached and asked to volunteer to
play one of the following roles:
1. Regional 'champions', based in areas in which there are
units which have been randomised to the intervention
arm, and who will be recruited by CEMACH, given the rel-
evant information, and asked to attend the first and sec-
ond intervention meetings and provide ongoing support
to local clinicians (see Interventions, below);
2. Clinicians in units which have been randomised to the
intervention arm will also be nominated by CEMACH,
given the relevant information, asked to attend the second
intervention meeting only, and to then work at imple-
mentation of the BAPM guidelines in their local unit (see
Interventions, below).
All babies born at < 27 weeks' gestation in England during
the study period will be identified using the dataset of
another national study on premature babies running at
the same time as the BEADI study [38], Epicure2, which
investigates survival and long term outcomes of prema-
ture infants below 27 weeks' gestation in England in 2006
compared to the outcome in 1995 [39].
Intervention
Overall, the intervention design will be based on interven-
tion(s) aimed at groups of specific health professionals
that have been shown to be effective in isolation or in
association (multifaceted) in adult medicine and in par-
ticular in UK, and neonatal care in a North American con-
text (see Background), [3,8,11,17,18,30-33].
The intervention process will include two meetings (Fig
1):
1. At the first meeting, the regional 'champions' will come
together: to explore the theory and practice of NHS organ-
isational change; to consider the role of champions as
leaders; to understand behaviour change principles and
the human dimension of changes, and to develop practi-
cal skills to effect and sustain change in order to support
health care staff in their workplace. They will be super-
vised by trainers with expertise in organisational change.
2. At the second meeting, the regional champions and
consultant/senior nurses/leads for clinical governance
from each intervention unit will then come together to:
explore clinical areas identified for changes (with evi-
dence based lectures from national clinical leaders);
Flow chart of the CRCT Figure 1
Flow chart of the CRCT.
CEMACH post- intervention data collection:
Download of outcome of interest 
CEMACH post- intervention data collection:
Download of outcome of interest 
86 neonatal units randomised to intervention:
As per control arm + regional champions and local 
clinicians interacting to modify practice after joint
training in management changes and evidence-
based practice in focused area of care (temperature,
surfactant and resuscitation team at birth).
 96 neonatal units randomised to control arm:
Usual dissemination strategies
(report sent to hospitals and guidelines on website) +
 dissemination package with PowerPoint slides
to each hospital neonatal clinical lead 
CEMACH Epicure2 pre-intervention data 
collection:
 Download of an anonymised dataset from Epicure2
survey containing chosen outcome of interest +
basic demographics 
n= 182 neonatal units in EnglandImplementation Science 2007, 2:33 http://www.implementationscience.com/content/2/1/33
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understand benchmarking of individual policies and
practices; and to be introduced to tools for achieving
changes in practice. They will then be asked to determine
actions required to develop responses to suggested areas
of changes locally and to support the processes needed to
achieve these changes. They will also be supervised by the
same trainers at the first meeting, who are experts in
organisational change.
The control arm will be based on the current dissemina-
tion strategies (report sent, guidelines on website), which
includes a dissemination package with PowerPoint slides
(Fig 1).
Choice of outcomes
The primary policy and practice outcomes must meet cer-
tain criteria. First, they need to be important for babies.
Also, they must be able to be affected by implementing
interventions that are evidence-based. Finally, the out-
comes must be likely to be affected by an active dissemi-
nation intervention (i.e. not already used so extensively
that there is no capacity for increased implementation).
Two 'practice' outcomes that fulfil these criteria have been
identified. First, the timing of surfactant administration at
birth: Project 27/28 reported delays in surfactant adminis-
tration in over 40% of cases [34,40] that were amenable
to change in the US trial [21] of active dissemination strat-
egies. Second, the temperature control of premature
babies at birth: Project 27/28 showed that poor thermal
control was strongly associated with death [34,40] and
hypothermia may be prevented easily by using polyethyl-
ene occlusive skin wrapping to prevent heat loss in labour
ward as soon as the premature baby is born [41]. Qualifi-
cation and number of paediatric staff present at the deliv-
ery of a preterm infant has been identified as a 'policy'
outcome as Project 27/28 reported 45% of inadequate
staff cover at the time of the initial resuscitation of these
babies at birth [34].
All these policy and practice outcomes fulfil the first and
second criteria mentioned above, but there is currently
only anecdotal evidence to inform the third criterion
about the extent of use of these practices and policies.
Therefore, data to quantify the pre-intervention extent of
these policies and practices will be collected for each indi-
vidual unit and baby in the study (Fig 1). Rather than set-
ting up new national data collection, the BEADI study will
be collaborating with a related study [38] also working
with CEMACH and will be given an anonymised down-
load from the Epicure2 dataset (Fig 1). Post-intervention
data will be collected in the same way but additional data
will be collected by CEMACH within three months after
the intervention takes place to assess any trends in the out-
comes over time (Fig 1). Both data collections process will
be blind to the allocation intervention.
Power calculation
The power calculations for assessment of the policy out-
comes are based on the number of available hospitals
known at the time [42]. Working backwards from an esti-
mated 130 hospitals in England with neonatal intensive
care facilities for premature babies that have been
enrolled in the Epicure2 study, and considering a likely
range of percentages which may have already imple-
mented the relevant policies in the control hospitals (p1)
(the rates for the outcomes of interest will not be known
until analysis of the pre-intervention survey), we have cal-
culated what size of effect could be detected with 80%
power at 5% level of statistical significance (two-sided
test), given the constraint of this fixed number of hospi-
tals. For example, 126 hospitals are required to detect a
change of policy from 60% in the control arm (p1) to
82% in the intervention arm (p2) with a size of effect (RR)
of 1.4, irrespective of the number of babies (Table 1). Sim-
ilarly, the power calculations for assessment of changes in
practice outcomes are based on the number of babies clus-
tered in the 130 hospitals. According to estimates from
Epicure [39], one can expect 1650 annual admissions to
neonatal intensive care from 3,500 births of babies < 27
weeks in England. As the data collection is based on fixed
three month periods, the number of babies we can expect
over three months is approximately 400 admissions and
850 births. Again, working backwards from numbers
available, and additionally making assumptions about
intra-cluster correlation coefficients (from published
databases of likely intra-cluster correlation coefficient
(ICC) in active dissemination research in previous trials),
the trial is likely to have enough power to detect a range
Table 1: Power calculation for policies assessment
% with policy in 
control arm (p1)
% with policy in 
intervention arm (p2)
Size of 
effect (RR)
Total number of hospitals needed to detect with 80% power at 5% 
level of statistical significance (two-sided test)
60 82 1.4 126
55 78 1.4 124
50 74 1.5 121
45 69 1.5 126
40 64 1.6 128
35 59 1.6 128Implementation Science 2007, 2:33 http://www.implementationscience.com/content/2/1/33
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of practice changes. For example, 400 admissions will
have around 80% power to detect a difference in practices
from 40% to 55% (5% two-sided significance) with ICC
of 0.06, and 850 births will have more than 80% power to
detect a same difference even for an ICC of 0.25 (Tables 2,
3, 4).
After completing the power calculations, further relevant
hospitals were identified via the Epicure2 study [38]
(increasing the sample from the estimated 130 to 182
hospitals). The power calculations are therefore conserva-
tive.
Analysis
Statistical analysis of the RCT will be based on Intention
to Treat (ITT) principles, comparing outcomes from all
the hospitals allocated to active intervention with those
allocated to control. Both for policies and for practice out-
comes, the emphasis will be on differences between these
groups post-intervention, and on differences between
these groups in terms of changes between the pre-inter-
vention and post-intervention phases when data are avail-
able pre-intervention. For the policies, this will be based
on hospitals, but for practice outcomes, this will be based
on babies within hospitals, taking appropriate account of
the clustering.
Ethical considerations
The approach and recruitment process for RCTs involving
clusters (and especially involving educational interven-
tions) is recognised to be different from that involving
randomising individuals, and is closer to Zelen randomi-
sation [43,44] in that randomisation comes before con-
sent, and consent to intervention is usually only asked
from those allocated to the active intervention arm. Infor-
mation about BEADI will also be made available on the
BAPM website [23]. Selected data items will be anony-
mously downloaded to CEMACH from the Epicure2
Table 3: Power calculation for changes in practice for various assumptions of % with practice pre-intervention – p1 (20–60%), p2 (30–
90%), assuming 80% power at 5% level of statistical significance (2-sided test), for sizes of effect ≤ 2 and for cluster size three (numbers 
of babies admitted per hospital)
ICC assumption required for 390 babies
p1 P2
30 35 40 45 50 55 60 65 70 75 80 85 90
60 0.14
55 0.01 0.6
50 0.07 0.54
45 0.06 0.5
40 0.06 0.5
35 0.07 0.5
30 0.1 0.54
25 0.14 0.6
20 0.2
Table 2: Power calculation for changes in practice for various assumptions of % with practice pre-intervention – p1(20–60%), p2 (30–
90%), assuming 80% power at 5% level of statistical significance (2-sided test), for sizes of effect ≤ 2 and assuming no clustering (ie ICC 
= 0.00)
Total number of babies needed
p1 P2
30 35 40 45 50 55 60 65 70 75 80 85 90
60 712 304 162 98 62
55 752 324 176 108 70 48
50 774 338 186 116 76 54 38
45 782 346 192 120 82 58 42 32
40 774 346 194 122 84 60 44
35 752 388 192 122 84 62
30 712 324 186 120 84
25 656 304 176 116
20 546 276 162Implementation Science 2007, 2:33 http://www.implementationscience.com/content/2/1/33
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study (approved by Multi-centre Research Ethics Commit-
tees (MREC)- East London and the City Research Ethics
Committee 2005) for the purpose of the BEADI study.
Anonymised data will be stored securely within CEMACH
indefinitely as per the CEMACH Information Security Pol-
icy. Any data identifying clinicians who have agreed to
participate will only be stored by the trial team for the
duration of the study and subsequent analysis, and will be
anonymised for reporting. MREC approval was awarded
for the BEADI study by the East London and the City
Research Ethics Committee on 17 November 2005. A sub-
sequent qualitative study on barriers to changes is
planned and will be part of a separate protocol and sub-
mission to MREC.
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